These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1364 related articles for article (PubMed ID: 30594776)

  • 1. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
    Zhang M; He Q; Chen G; Li PA
    Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease.
    Haque ME; Akther M; Jakaria M; Kim IS; Azam S; Choi DK
    Mov Disord; 2020 Jan; 35(1):20-33. PubMed ID: 31680318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
    Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
    Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease.
    Han QQ; Le W
    Neurosci Bull; 2023 May; 39(5):832-844. PubMed ID: 36757612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UFL1 modulates NLRP3 inflammasome activation and protects against pyroptosis in LPS-stimulated bovine mammary epithelial cells.
    Li C; Wang X; Kuang M; Li L; Wang Y; Yang F; Wang G
    Mol Immunol; 2019 Aug; 112():1-9. PubMed ID: 31078114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
    Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
    Front Immunol; 2021; 12():719807. PubMed ID: 34691027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mitochondria in NLRP3 inflammasome activation.
    Liu Q; Zhang D; Hu D; Zhou X; Zhou Y
    Mol Immunol; 2018 Nov; 103():115-124. PubMed ID: 30248487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1β release.
    Martín-Sánchez F; Martínez-García JJ; Muñoz-García M; Martínez-Villanueva M; Noguera-Velasco JA; Andreu D; Rivas L; Pelegrín P
    Cell Death Dis; 2017 Aug; 8(8):e2984. PubMed ID: 28796264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
    Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
    Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
    Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
    Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
    Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations.
    Nguyen LTN; Nguyen HD; Kim YJ; Nguyen TT; Lai TT; Lee YK; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(7):2117-2133. PubMed ID: 35988226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurine Alleviates Schistosoma-Induced Liver Injury by Inhibiting the TXNIP/NLRP3 Inflammasome Signal Pathway and Pyroptosis.
    Liu X; Zhang YR; Cai C; Ni XQ; Zhu Q; Ren JL; Chen Y; Zhang LS; Xue CD; Zhao J; Qi YF; Yu YR
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
    Guo M; An F; Yu H; Wei X; Hong M; Lu Y
    Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.